AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 213 min read$ISRG

Intuitive Surgical Inc (ISRG) (Q3 2026) Earnings Call Highlights: Revenue Jumps 22%

Intuitive Surgical (ISRG) reported Q3 2026 revenue of $3B, up 22%, with net da Vinci placements rising 40%. U.S. procedure growth slowed to 10%, the lowest since COVID, due to tough comparisons and potential headwinds. China's operating environment remains challenging. A $450M litigation settlement reduced GAAP net income to $523M. The company expects pricing actions to lower da Vinci I&A revenue per procedure by 3-5%.

Original reporting
finance.yahoo.com
Published Oct 21, 2026, 7:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 7:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Intuitive Surgical Inc (ISRG) (Q3 2026) Earnings Call Highlights: Revenue Jumps 22% — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$ISRGNeutralMed
01

Why it matters

The earnings beat may be tempered by disclosed margin pressures, prompting traders to reassess short‑term price targets.

02

Market read

First‑time disclosure of Q3 earnings and forward pricing guidance makes this a material news event for ISRG.

03

What to watch

Extended‑use program and AI‑driven features may unlock higher per‑case revenue beyond the stated 3‑5% dip.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Intuitive Surgical reported Q3 2026 results, highlighting revenue growth, a large litigation settlement, and upcoming pricing changes in the U.S. and China.

Company-level read

Ticker impact

$ISRGNeutralHigh confidence
Context

Q3 2026 earnings call disclosed 22% revenue growth, $450M litigation settlement, and upcoming pricing headwinds impacting future margins.

Expected impact

likely modest downside as investors price in 3‑5% per‑procedure revenue hit and $450M hit to net income.

Evidence & confidence

Strong top‑line offset by explicit cost and margin headwinds; market will likely adjust on the pricing guidance.

Market effects

Sector

Medtech firms may face pricing pressure in China and the U.S.; ASC adoption could boost placement volumes.

Regional

U.S. and China markets may see slight pullback in robotics‑related stocks.

Global

Limited to surgical robotics niche; broader market impact minimal.

Counterpoint

What could challenge this read

Despite pricing headwinds, the 22% revenue surge and expanding ASC footprint could support upside if guidance beats expectations.

Key entities

  • Company
    Intuitive Surgical Inc.

    Provider of da Vinci surgical robots.

  • Executive
    David Rosa

    CEO of Intuitive Surgical.

  • Executive
    Jamie Samath

    CFO of Intuitive Surgical.

Read at source← All news

StoryIntuitive Surgical posts Q3 2026 earnings beat and narrows 2026 procedure‑growth outlook

Also covered by

4 outlets

Related articles

OCT 21
$ISRGMedAI 8/10

What Intuitive Surgical (ISRG) Said on Its Q3 Earnings Call

Intuitive Surgical (ISRG) reported Q3 earnings, highlighting 65% of global da Vinci placements were for its 5 and SP systems. The company installed 18 systems in U.S. ambulatory surgery centers, including 15 XiR systems. ISRG placed 56 Ion systems, up from 50 a year earlier. Non-GAAP operating margin was 42% (41% excluding a one-time tariff refund). GAAP net income was $523M, down from $704M a year earlier.

finance.yahoo.com3 min
OCT 20
$ISRGHighAI 8/10

Intuitive Surgical revised its 2026 forecast for da Vinci robotic-surgery procedures, expecting growth closer to the…

Intuitive Surgical revised its 2026 forecast for da Vinci robotic-surgery procedures, expecting growth closer to the midpoint of its 14%-15% range, down from 13.5%-15.5%. Shares fell 7% in extended trading. Q3 revenue was $3.05B, beating estimates of $2.91B, with adjusted profit of $3 per share, above the $2.64 estimate. The company also announced plans for an Extended Use Program to reduce instrument costs.

srnnews.com2 min
OCT 20
$ISRGMedAI 8/10

Intuitive Surgical, Inc (ISRG) Q3 2026 Earnings Call Transcript

Intuitive Surgical (ISRG) reported Q3 2026 earnings, highlighting 15% total procedure growth, with 14% in da Vinci and 31% in Ion procedures. U.S. da Vinci growth was 10%, while international growth was 20%. The company installed over 13,200 da Vinci and Ion systems worldwide. Revenue growth was driven by strong demand for da Vinci 5 and SP platforms, with 28% increase in system placements. The company also announced plans for a new manufacturing facility in Malaysia.

news.alphastreet.com3 min